Next Milestone Ventures
Calder Biosciences is a vaccine immunogen design company that is developing novel RSV and universal Influenza subunit vaccines, both representing $ multi-billion market opportunities with mitigated clinical risk.
Christopher Marshall, Ph.D., Chief Executive Officer
Mark Yonda, Ph. D., Director of Research
Next Milestone is a Program of